News & Updates

The time of steroids as the treatment of choice for asthma and chronic obstructive pulmonary disease (COPD) exacerbations appears to be nearing its end with the arrival of a new monoclonal antibody therapy, according to the results of the ABRA study.

Several barriers on the system and organizational levels disrupt the continuous implementation of SmartMoves, an evidence-based intensive health behaviour and lifestyle treatment (IHBLT) program, for children with obesity, a study has shown.

Low-intensity obesity interventions modestly reduce BMI in children, with one in five kids in the telephonic coaching condition achieving meaningful improvement in BMI z score, reports a recent study.